Baxter International's latest marketcap:
As of 11/04/2025, Baxter International's market capitalization has reached $9.35 B. According to our data, Baxter International is the 2191th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 9.35 B |
| Revenue (ttm) | 11.02 B |
| Net Income (ttm) | -341,000,000 |
| Shares Out | 513.62 M |
| EPS (ttm) | -0.67 |
| Forward PE | 8.27 |
| Ex-Dividend Date | 08/29/2025 |
| Earnings Date | 10/30/2025 |
Baxter International's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 11/04/2025 | $9.35 B | -36.28% | 2191 |
| 12/31/2024 | $14.89 B | -24.09% | 1209 |
| 12/29/2023 | $19.61 B | -23.67% | 909 |
| 12/30/2022 | $25.7 B | -40.22% | 656 |
| 12/31/2021 | $42.98 B | 4.86% | 454 |
| 12/31/2020 | $40.99 B | -3.99% | 411 |
| 12/31/2019 | $42.69 B | 21.89% | 313 |
| 12/31/2018 | $35.03 B | -0.55% | 312 |
| 12/29/2017 | $35.22 B | 46.03% | 355 |
| 12/30/2016 | $24.12 B | 15.57% | 424 |
Company Profile
About Baxter International Inc.
Baxter International Inc., through its subsidiaries, delivers a diverse range of healthcare products across the United States and globally. The company operates through three key segments:
- Medical Products and Therapies
- Healthcare Systems and Technologies
- Pharmaceuticals
Key Offerings
Baxter provides an extensive portfolio of healthcare solutions, including:
- Sterile intravenous (IV) solutions and infusion systems
- Parenteral nutrition therapies and administrative sets
- Generic injectable pharmaceuticals
- Surgical hemostats, sealants, and advanced surgical equipment
- Smart bed systems and patient monitoring technologies
- Respiratory health devices and operating room integration tools
- Specialty injectable pharmaceuticals and inhaled anesthetics
- Drug compounding services
Market Reach
Baxter's products serve a wide range of healthcare settings, such as:
- Hospitals and nursing homes
- Rehabilitation and ambulatory surgery centers
- Doctors’ offices and kidney dialysis centers
- Home-based patient care under physician supervision
Distribution & Partnerships
The company distributes its products through:
- Direct sales teams
- Independent distributors and drug wholesalers
- Specialty pharmacy providers
Baxter has also partnered with Celerity Pharmaceuticals, LLC to develop acute care generic injectable premix and oncolytic products.
Global Presence
Baxter operates across multiple regions, including:
- Eastern Europe, Middle East, and Africa
- Latin America, Asia, and Western Europe
- Canada, Japan, Australia, and New Zealand
Founded: 1931 | Headquarters: Deerfield, Illinois
Frequently Asked Questions
-
What is Baxter International's (BAX) current market cap?As of 11/04/2025, Baxter International (including the parent company, if applicable) has an estimated market capitalization of $9.35 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Baxter International (BAX) rank globally by market cap?Baxter International global market capitalization ranking is approximately 2191 as of 11/04/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.